TY - JOUR
T1 - Same family, different species
T2 - methodological conduct and quality varies according to purpose for five types of knowledge synthesis
AU - Tricco, Andrea C.
AU - Zarin, Wasifa
AU - Ghassemi, Marco
AU - Nincic, Vera
AU - Lillie, Erin
AU - Page, Matthew J.
AU - Shamseer, Larissa
AU - Antony, Jesmin
AU - Rios, Patricia
AU - Hwee, Jeremiah
AU - Veroniki, Areti Angeliki
AU - Moher, David
AU - Hartling, Lisa
AU - Pham, Ba'
AU - Straus, Sharon E.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Objectives: The aim of the study was to characterize methodological conduct, reporting, and quality of five knowledge synthesis (KS) approaches. Study Design and Setting: Retrospective analysis of a convenience sample of five published databases of KS approaches: overview of reviews (n = 74), scoping reviews (n = 494), rapid reviews (n = 84), systematic reviews (n = 300), and network meta-analyses (NMAs; n = 456). Data in the five published databases were abstracted by two reviewers independently, any missing data for this retrospective analysis were abstracted by one experienced reviewer. Methods were appraised using the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) tool. Descriptive analysis was performed. Results: Reporting the use of a protocol ranged from 4% for rapid reviews to 32% for systematic reviews. The use of two reviewers for citation and full-text screening ranged from 20% for scoping reviews to 60% for NMAs. Data abstraction was performed in duplicate for 11% of rapid reviews and 54% of NMAs, and for risk of bias appraisal, this ranged from 6% for scoping reviews to 41% for NMAs. NMAs had the highest median percentage of maximum obtainable AMSTAR score (64%; Q1–Q3:45–73%), while scoping reviews had the lowest (25%; Q1–Q3:13–38%). Conclusion: NMAs consistently scored the highest on the AMSTAR tool likely because the purpose is to estimate treatment effects statistically. Scoping reviews scored the lowest (even after adjusting the score for not relevant items) likely because the purpose is to characterize the literature.
AB - Objectives: The aim of the study was to characterize methodological conduct, reporting, and quality of five knowledge synthesis (KS) approaches. Study Design and Setting: Retrospective analysis of a convenience sample of five published databases of KS approaches: overview of reviews (n = 74), scoping reviews (n = 494), rapid reviews (n = 84), systematic reviews (n = 300), and network meta-analyses (NMAs; n = 456). Data in the five published databases were abstracted by two reviewers independently, any missing data for this retrospective analysis were abstracted by one experienced reviewer. Methods were appraised using the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) tool. Descriptive analysis was performed. Results: Reporting the use of a protocol ranged from 4% for rapid reviews to 32% for systematic reviews. The use of two reviewers for citation and full-text screening ranged from 20% for scoping reviews to 60% for NMAs. Data abstraction was performed in duplicate for 11% of rapid reviews and 54% of NMAs, and for risk of bias appraisal, this ranged from 6% for scoping reviews to 41% for NMAs. NMAs had the highest median percentage of maximum obtainable AMSTAR score (64%; Q1–Q3:45–73%), while scoping reviews had the lowest (25%; Q1–Q3:13–38%). Conclusion: NMAs consistently scored the highest on the AMSTAR tool likely because the purpose is to estimate treatment effects statistically. Scoping reviews scored the lowest (even after adjusting the score for not relevant items) likely because the purpose is to characterize the literature.
KW - Knowledge synthesis
KW - Network meta-analysis
KW - Overview of reviews
KW - Rapid review
KW - Scoping review
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85034953309&partnerID=8YFLogxK
U2 - 10.1016/j.jclinepi.2017.10.014
DO - 10.1016/j.jclinepi.2017.10.014
M3 - Review article (Academic Journal)
C2 - 29103958
AN - SCOPUS:85034953309
VL - 96
SP - 133
EP - 142
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
SN - 0895-4356
ER -